These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease. Irizarry MC; Gurol ME; Raju S; Diaz-Arrastia R; Locascio JJ; Tennis M; Hyman BT; Growdon JH; Greenberg SM; Bottiglieri T Neurology; 2005 Nov; 65(9):1402-8. PubMed ID: 16275827 [TBL] [Abstract][Full Text] [Related]
23. Homocysteine, Alzheimer genes and proteins, and measures of cognition and depression in older men. Flicker L; Martins RN; Thomas J; Acres J; Taddei K; Norman P; Jamrozik K; Almeida OP J Alzheimers Dis; 2004 Jun; 6(3):329-36. PubMed ID: 15201487 [TBL] [Abstract][Full Text] [Related]
24. Combination of plasma tumor necrosis factor receptors signaling proteins, beta-amyloid and apolipoprotein E for the detection of Alzheimer's disease. Zhang J; Jia J; Qin W; Wang S Neurosci Lett; 2013 Apr; 541():99-104. PubMed ID: 23500026 [TBL] [Abstract][Full Text] [Related]
25. Association of Plasma Amyloid-β and Dementia Among Black and White Older Adults. Jiang X; Bahorik AL; Graff-Radford NR; Yaffe K J Alzheimers Dis; 2024; 99(2):787-797. PubMed ID: 38701147 [TBL] [Abstract][Full Text] [Related]
26. Cross-Sectional Associations of Total Plasma Homocysteine with Cortical β-Amyloid Independently and as a Function of Omega 3 Polyunsaturated Fatty Acid Status in Older Adults at Risk of Dementia. Hooper C; De Souto Barreto P; Coley N; Caussé E; Payoux P; Salabert AS; Cesari M; Andrieu S; Bowman GL; Weiner M; Vellas B J Nutr Health Aging; 2017; 21(10):1075-1080. PubMed ID: 29188863 [TBL] [Abstract][Full Text] [Related]
28. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine. Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of dementia by acrolein, amyloid-β and creatinine. Igarashi K; Yoshida M; Waragai M; Kashiwagi K Clin Chim Acta; 2015 Oct; 450():56-63. PubMed ID: 26196945 [TBL] [Abstract][Full Text] [Related]
30. Candidate genes for Alzheimer's disease are associated with individual differences in plasma levels of beta amyloid peptides in adults with Down syndrome. Schupf N; Lee A; Park N; Dang LH; Pang D; Yale A; Oh DK; Krinsky-McHale SJ; Jenkins EC; Luchsinger JA; Zigman WB; Silverman W; Tycko B; Kisselev S; Clark L; Lee JH Neurobiol Aging; 2015 Oct; 36(10):2907.e1-10. PubMed ID: 26166206 [TBL] [Abstract][Full Text] [Related]
31. Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease. Qiu WQ; Zhu H; Dean M; Liu Z; Vu L; Fan G; Li H; Mwamburi M; Steffens DC; Au R Int J Geriatr Psychiatry; 2016 Mar; 31(3):316-22. PubMed ID: 26250797 [TBL] [Abstract][Full Text] [Related]
32. Sleep Deprivation Induced Plasma Amyloid-β Transport Disturbance in Healthy Young Adults. Wei M; Zhao B; Huo K; Deng Y; Shang S; Liu J; Li Y; Ma L; Jiang Y; Dang L; Chen C; Wei S; Zhang J; Yang H; Gao F; Qu Q J Alzheimers Dis; 2017; 57(3):899-906. PubMed ID: 28304302 [TBL] [Abstract][Full Text] [Related]
34. Effects of medications on plasma amyloid beta (Abeta) 42: longitudinal data from the VITA cohort. Blasko I; Jungwirth S; Jellinger K; Kemmler G; Krampla W; Weissgram S; Wichart I; Tragl KH; Hinterhuber H; Fischer P J Psychiatr Res; 2008 Sep; 42(11):946-55. PubMed ID: 18155247 [TBL] [Abstract][Full Text] [Related]
35. Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy? Tholen S; Schmaderer C; Chmielewski S; Förstl H; Heemann U; Baumann M; Steubl D; Grimmer T J Alzheimers Dis; 2016; 50(3):791-6. PubMed ID: 26682683 [TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E genotype modulates effects of vitamin B12 and homocysteine on grey matter volume in Alzheimer's disease. Lee YM; Ha JK; Park JM; Lee BD; Moon E; Chung YI; Kim JH; Kim HJ; Mun CW; Kim TH; Kim YH Psychogeriatrics; 2016 Jan; 16(1):3-11. PubMed ID: 25919635 [TBL] [Abstract][Full Text] [Related]
38. Association of plasma β-amyloid 40 and 42 concentration with type 2 diabetes among Chinese adults. Peng X; Xu Z; Mo X; Guo Q; Yin J; Xu M; Peng Z; Sun T; Zhou L; Peng X; Xu S; Yang W; Bao W; Shan Z; Li X; Liu L Diabetologia; 2020 May; 63(5):954-963. PubMed ID: 32034441 [TBL] [Abstract][Full Text] [Related]
39. Plasma concentrations of the amyloid-β peptides in young volunteers: the influence of the APOE genotype. Zimmermann R; Huber E; Schamber C; Lelental N; Mroczko B; Brandner S; Maler JM; Oberstein T; Szmitkowski M; Rauh M; Kornhuber J; Lewczuk P J Alzheimers Dis; 2014; 40(4):1055-60. PubMed ID: 24577473 [TBL] [Abstract][Full Text] [Related]
40. Generation of Rabbit Monoclonal Antibody to Amyloid-β38 (Aβ38): Increased Plasma Aβ38 Levels in Down Syndrome. Mehta PD; Patrick BA; Barshatzky M; Mehta SP; Frackowiak J; Mazur-Kolecka B; Miller DL J Alzheimers Dis; 2015; 46(4):1021-32. PubMed ID: 26402629 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]